Cell-Easy is a CDMO that specializes in preclinical and clinical drug development.
Cell-Easy has raised $8.7M in total funding. The most recent round was Undisclosed. The last funding was announced in February 2022.
Cell-Easy's investors include Bpifrance.
Cell-Easy is headquartered in Toulouse, France.
Cell-Easy is a CDMO that specializes in preclinical and clinical drug development.
Cell-Easy is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cell-Easy — Funding & Investors." VCBacked, February 28, 2022, https://www.vcbacked.co/company/cell-easy. Accessed August 14, 2026.
VCBacked. (2022). Cell-Easy — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/cell-easy
{{cite web |title=Cell-Easy — Funding & Investors |url=https://www.vcbacked.co/company/cell-easy |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated